HIGHLIGHTS
- who: Margaret E. Brousseau from the Cardiovascular Research LaboratoryTufts University have published the Article: Effects of cholesteryl ester transfer protein inhibition on apolipoprotein A-II-containing HDL subspecies and apolipoprotein A-II metabolism, in the Journal: (JOURNAL) of 28/08/2008
- what: Subjects having an LDL cholesterol of.160 mg/dl were considered for the atorvastatin arm of this study provided that they met all other criteria, including that of an LDL cholesterol of,160 mg/dl once stabilized on 20 mg atorvastatin. Given the key role that apoA-II plays in HDL metabolism, this . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.